We are live on ! Find out more
SONM icon

DNA X Inc

15 hedge funds and large institutions have $1.13M invested in DNA X Inc in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

33% more capital invested

Capital invested by funds: $849K → $1.13M (+$280K)

0% less ownership

Funds ownership: 0.02%0.01% (-0%)

21% less funds holding

Funds holding: 1915 (-4)

50% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 8

Holders
15
Holders Change
-4
Holders Change %
-21.05%
% of All Funds
0.22%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
3
Reduced
2
Closed
8
Calls
Puts
Net Calls
Net Calls Change

SONM Hedge Fund Activity: Q2 2024 in Review

15 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in DNA X Inc (SONM) for Q2 2024, worth a combined $1.13M — up 33% from $849K a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of SONM and 4 opened new positions — a net loss of 4 holders — while 2 trimmed existing stakes and 3 added.

The largest buyer was Two Sigma Securities, opening a new position worth an estimated $23.2K. The largest seller was Bank of New York Mellon, exiting entirely with an estimated $123K sold.

  • 15 institutional investors held DNA X Inc (SONM) as of Q2 2024, down from 19 in Q1 2024.
  • Funds reported $1.13M of DNA X Inc stock for Q2 2024, up 33% quarter-over-quarter.
  • 4 funds opened new DNA X Inc positions in Q2 2024 and 8 closed out, a net change of -4 holders.
  • The largest DNA X Inc buyer in Q2 2024 was Two Sigma Securities, an estimated $23.2K added.
  • The largest DNA X Inc seller in Q2 2024 was Bank of New York Mellon, an estimated $123K sold.

Based on aggregated 13F filings for Q2 2024.